Pubnol-ET Tablet
Marketer
Mitis Biomedics Ltd
Salt Composition
Etizolam (0.5mg) + Propranolol (20mg)
Overview Pubnol-ET Tablet
Anxiety is treated with the prescription medication, Pubnol-ET Tablet. This medication reduces excessive neuronal activity in the brain, promoting calmness. It also inhibits certain neurotransmitters affecting the cardiovascular system. Administer Pubnol-ET Tablet on an empty stomach, consistently at the same time daily for optimal blood levels. Follow your physician's prescribed dosage and duration meticulously, as it carries a significant risk of dependence. If a dose is missed, take it immediately upon recall. Complete the entire course of treatment, even if symptoms improve. Abrupt cessation should be avoided due to potential withdrawal effects. Alcohol consumption should be avoided while using this medication, as it can impair its efficacy. Common adverse effects may include drowsiness, confusion, bradycardia, memory difficulties, and nightmares. Dizziness and fatigue are also possible. Refrain from activities demanding concentration until the medication's effects are known. Report any significant leg or ankle edema, sudden weight increase, or dyspnea to your doctor immediately. Individuals with hepatic impairment should exercise caution and inform their doctor of all concurrent medications, as interactions may reduce Pubnol-ET's effectiveness or alter its action. Disclose any pregnancy, pregnancy plans, or breastfeeding to your physician.
Primary Ingredients of Pubnol-ET Tablet
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Pubnol-ET Tablet
Managing Anxiety: Therapeutic Approaches
Major Benefits of Pubnol-ET Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Pubnol-ET Tablet whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.
Common Side effects of Pubnol-ET Tablet:
- Confusion
- Memory impairment
- Drowsiness
- Slow heart rate
- Tiredness
- Uncoordinated body movements
- Nightmares
- Cold extremities
How to use Pubnol-ET Tablet:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Pubnol-ET Tablet on an empty stomach.
How Pubnol-ET Tablet works:
Pubnol-ET Tablet combines etizolam, a benzodiazepine, and propranolol, a beta-blocker. Etizolam enhances the effects of GABA, a neurotransmitter that calms overactive brain cells. Propranolol counteracts specific chemical messengers affecting the cardiovascular system, thus lowering heart rate, blood pressure, and cardiac workload.
SAFETY ADVICE
AlcoholUNSAFE
Avoid alcohol while taking Pubnol-ET Tablets.
PregnancyCONSULT YOUR DOCTOR
The use of Pubnol-ET Tablet during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the potential advantages against any possible risks prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on Pubnol-ET Tablet use while breastfeeding is lacking. Seek medical advice from your physician.
DrivingUNSAFE
Driving may be impaired by Pubnol-ET Tablet side effects, including visual disturbances, hallucinations, fatigue, cognitive impairment, dizziness, and drowsiness.
KidneyCONSULT YOUR DOCTOR
Data regarding Pubnol-ET Tablet use in patients with renal impairment is scarce. Physician consultation is recommended.
LiverCAUTION
Patients with hepatic impairment should exercise caution when using Pubnol-ET Tablets, potentially requiring dosage modification. Physician consultation is recommended. Routine blood pressure monitoring is advised to guide dosage adjustments.
What if you forget to take Pubnol-ET Tablet :
Should you forget a Pubnol-ET Tablet dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Pubnol-ET Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Neuroscience and Central Nervous System |



